
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8638171
[patent_doc_number] => 20130029974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => '6,7-DIHYDROIMIDAZO[1,5-A]PYRAZIN-8(5H)-ONE DERIVATIVES AS PROTEIN KINASE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/575181
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11901
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575181
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575181 | 6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one derivatives as protein kinase modulators | Jan 20, 2011 | Issued |
Array
(
[id] => 8904792
[patent_doc_number] => 20130172294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Treatment with VB-201'
[patent_app_type] => utility
[patent_app_number] => 13/520719
[patent_app_country] => US
[patent_app_date] => 2011-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16202
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520719
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520719 | Treatment with VB-201 | Jan 4, 2011 | Abandoned |
Array
(
[id] => 8815274
[patent_doc_number] => 20130116319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Agent for Treating Parkinson\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 13/518814
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518814
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/518814 | Agent for treating Parkinson's disease | Dec 22, 2010 | Issued |
Array
(
[id] => 11684055
[patent_doc_number] => 09682087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Nestorone®/estradiol transdermal gel'
[patent_app_type] => utility
[patent_app_number] => 13/515552
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6138
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515552 | Nestorone®/estradiol transdermal gel | Dec 16, 2010 | Issued |
Array
(
[id] => 10192877
[patent_doc_number] => 09221773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Benzamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/517497
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10165
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/517497 | Benzamide derivatives | Dec 16, 2010 | Issued |
Array
(
[id] => 9762358
[patent_doc_number] => 08846682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Compound suitable for the treatment of synucleopathies'
[patent_app_type] => utility
[patent_app_number] => 13/516543
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 9
[patent_no_of_words] => 6922
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516543 | Compound suitable for the treatment of synucleopathies | Dec 15, 2010 | Issued |
Array
(
[id] => 8830082
[patent_doc_number] => 20130131127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'METHOD OF USING DOPAMINE REUPTAKE INHIBITORS AND THEIR ANALOGS FOR TREATING DIABETES SYMPTOMS AND DELAYING OR PREVENTING DIABETES-ASSOCIATED PATHOLOGIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/509881
[patent_app_country] => US
[patent_app_date] => 2010-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7334
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509881
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/509881 | Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions | Dec 2, 2010 | Issued |
Array
(
[id] => 5977750
[patent_doc_number] => 20110071102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Compositions and Methods to Treat Recurrent Medical Conditions'
[patent_app_type] => utility
[patent_app_number] => 12/956769
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14627
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071102.pdf
[firstpage_image] =>[orig_patent_app_number] => 12956769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/956769 | Compositions and methods to treat recurrent medical conditions | Nov 29, 2010 | Issued |
Array
(
[id] => 9710378
[patent_doc_number] => 08834943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Compositions containing amines and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/957318
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9277
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12957318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/957318 | Compositions containing amines and use thereof | Nov 29, 2010 | Issued |
Array
(
[id] => 5978112
[patent_doc_number] => 20110071177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'FUNGICIDAL ACTIVE SUBSTANCE COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 12/953070
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6263
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071177.pdf
[firstpage_image] =>[orig_patent_app_number] => 12953070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/953070 | FUNGICIDAL ACTIVE SUBSTANCE COMBINATION | Nov 22, 2010 | Abandoned |
Array
(
[id] => 8815214
[patent_doc_number] => 20130116259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'COMBINATION THERAPY FOR TREATING OR PREVENTING AN INFLAMMATORY SKIN DISORDER'
[patent_app_type] => utility
[patent_app_number] => 13/510302
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10576
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510302
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/510302 | Combination therapy for treating or preventing an inflammatory skin disorder | Nov 17, 2010 | Issued |
Array
(
[id] => 6008115
[patent_doc_number] => 20110060146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'VITAMIN-D-LIKE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/946091
[patent_app_country] => US
[patent_app_date] => 2010-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137645
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12946091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/946091 | VITAMIN-D-LIKE COMPOUNDS | Nov 14, 2010 | Abandoned |
Array
(
[id] => 5987396
[patent_doc_number] => 20110098349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/939758
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26664
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939758 | CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS | Nov 3, 2010 | Abandoned |
Array
(
[id] => 17512553
[patent_doc_number] => 11291670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis
[patent_app_type] => utility
[patent_app_number] => 12/915709
[patent_app_country] => US
[patent_app_date] => 2010-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16302
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12915709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/915709 | Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis | Oct 28, 2010 | Issued |
Array
(
[id] => 8830000
[patent_doc_number] => 20130131045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'BENZAZEPINE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/504101
[patent_app_country] => US
[patent_app_date] => 2010-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6712
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504101
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504101 | Benzazepine compound | Oct 24, 2010 | Issued |
Array
(
[id] => 8347969
[patent_doc_number] => 20120208892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'EMESIS TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/501531
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5747
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501531
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501531 | EMESIS TREATMENT | Oct 14, 2010 | Abandoned |
Array
(
[id] => 8359690
[patent_doc_number] => 20120214853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'ITE for Cancer Intervention and Eradication'
[patent_app_type] => utility
[patent_app_number] => 13/503657
[patent_app_country] => US
[patent_app_date] => 2010-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9770
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503657 | ITE for cancer intervention and eradication | Oct 13, 2010 | Issued |
Array
(
[id] => 8336176
[patent_doc_number] => 20120202884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'INHIBITORS OF CXCR1/2 AS ADJUVANTS IN THE TRANSPLANT OF PANCREATIC ISLETS'
[patent_app_type] => utility
[patent_app_number] => 13/500544
[patent_app_country] => US
[patent_app_date] => 2010-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4430
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500544 | INHIBITORS OF CXCR1/2 AS ADJUVANTS IN THE TRANSPLANT OF PANCREATIC ISLETS | Oct 5, 2010 | Abandoned |
Array
(
[id] => 10876326
[patent_doc_number] => 08901113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Methods and compositions for deterring abuse'
[patent_app_type] => utility
[patent_app_number] => 12/893607
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14351
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12893607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/893607 | Methods and compositions for deterring abuse | Sep 28, 2010 | Issued |
Array
(
[id] => 9589398
[patent_doc_number] => 08778939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/498975
[patent_app_country] => US
[patent_app_date] => 2010-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67099
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/498975 | Compounds | Sep 26, 2010 | Issued |